IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-42972-2.html
   My bibliography  Save this article

Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy

Author

Listed:
  • Yuedong Guo

    (Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012)
    University of Chinese Academy of Sciences)

  • Qunqun Bao

    (Tongji University)

  • Ping Hu

    (Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012)
    Tongji University)

  • Jianlin Shi

    (Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012)
    Tongji University)

Abstract

Pro-tumoral macrophages in lung tumors present a significant challenge in immunotherapy. Here, we introduce a pH-responsive nanomedicine approach for activating anti-tumoral macrophages and dendritic cells. Using a layered double hydroxide nanosheet carrier, we co-deliver a T-type calcium channel inhibitor (TTA-Q6) and a CD47 inhibitor (RRX-001) into lung tumors. In the tumor acidic environment, TTA-Q6 is released, disrupting cancer cell calcium uptake, causing endoplasmic reticulum stress and inducing calreticulin transfer to the cell surface. Surface calreticulin activates macrophages and triggers dendritic cell maturation, promoting effective antigen presentation and therefore activating antitumor T cells. Simultaneously, RRX-001 reduces CD47 protein levels, aiding in preventing immune escape by calreticulin-rich cancer cells. In lung tumor models in male mice, this combined approach shows anti-tumor effects and immunity against tumor re-exposure, highlighting its potential for lung cancer immunotherapy.

Suggested Citation

  • Yuedong Guo & Qunqun Bao & Ping Hu & Jianlin Shi, 2023. "Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42972-2
    DOI: 10.1038/s41467-023-42972-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-42972-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-42972-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jia-Bin Wang & Ping Li & Xiao-Long Liu & Qiao-Ling Zheng & Yu-Bin Ma & Ya-Jun Zhao & Jian-Wei Xie & Jian-Xian Lin & Jun Lu & Qi-Yue Chen & Long-Long Cao & Mi Lin & Li-Chao Liu & Ning-Zi Lian & Ying-Ho, 2020. "An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer," Nature Communications, Nature, vol. 11(1), pages 1-14, December.
    2. F. Zhang & N. N. Parayath & C. I. Ene & S. B. Stephan & A. L. Koehne & M. E. Coon & E. C. Holland & M. T. Stephan, 2019. "Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers," Nature Communications, Nature, vol. 10(1), pages 1-16, December.
    3. Olivier Demaria & Stéphanie Cornen & Marc Daëron & Yannis Morel & Ruslan Medzhitov & Eric Vivier, 2019. "Publisher Correction: Harnessing innate immunity in cancer therapy," Nature, Nature, vol. 576(7785), pages 3-3, December.
    4. Olivier Demaria & Stéphanie Cornen & Marc Daëron & Yannis Morel & Ruslan Medzhitov & Eric Vivier, 2019. "Harnessing innate immunity in cancer therapy," Nature, Nature, vol. 574(7776), pages 45-56, October.
    5. Qi Peng & Xiangyan Qiu & Zihan Zhang & Silin Zhang & Yuanyuan Zhang & Yong Liang & Jingya Guo & Hua Peng & Mingyi Chen & Yang-Xin Fu & Haidong Tang, 2020. "PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade," Nature Communications, Nature, vol. 11(1), pages 1-8, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mengxue Zhou & Jiaxin Wang & Jiaxing Pan & Hui Wang & Lujia Huang & Bo Hou & Yi Lai & Fengyang Wang & Qingxiang Guan & Feng Wang & Zhiai Xu & Haijun Yu, 2023. "Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Katrin Rabold & Martijn Zoodsma & Inge Grondman & Yunus Kuijpers & Manita Bremmers & Martin Jaeger & Bowen Zhang & Willemijn Hobo & Han J. Bonenkamp & Johannes H. W. Wilt & Marcel J. R. Janssen & Lenn, 2022. "Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    3. Eric H. Bent & Luis R. Millán-Barea & Iris Zhuang & Daniel R. Goulet & Julia Fröse & Michael T. Hemann, 2021. "Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    4. Qian-Ni Ye & Long Zhu & Jie Liang & Dong-Kun Zhao & Tai-Yu Tian & Ya-Nan Fan & Si-Yi Ye & Hua Liu & Xiao-Yi Huang & Zhi-Ting Cao & Song Shen & Jun Wang, 2024. "Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    5. Yu-Hsuan Chen & Han-Hsiun Chen & Won-Jing Wang & Hsin-Yi Chen & Wei-Syun Huang & Chien-Han Kao & Sin-Rong Lee & Nai Yang Yeat & Ruei-Liang Yan & Shu-Jou Chan & Kuen-Phon Wu & Ruey-Hwa Chen, 2023. "TRABID inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    6. Caihua Zhang & Kang Li & Hongzhang Zhu & Maosheng Cheng & Shuang Chen & Rongsong Ling & Cheng Wang & Demeng Chen, 2024. "ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    7. Lucía López & Luciano Gastón Morosi & Federica Terza & Pierre Bourdely & Giuseppe Rospo & Roberto Amadio & Giulia Maria Piperno & Valentina Russo & Camilla Volponi & Simone Vodret & Sonal Joshi & Fran, 2024. "Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    8. Songlei Zhou & Yukun Huang & Yu Chen & Yipu Liu & Laozhi Xie & Yang You & Shiqiang Tong & Jianpei Xu & Gan Jiang & Qingxiang Song & Ni Mei & Fenfen Ma & Xiaoling Gao & Hongzhuan Chen & Jun Chen, 2023. "Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    9. Colin Y. C. Lee & Bethany C. Kennedy & Nathan Richoz & Isaac Dean & Zewen K. Tuong & Fabrina Gaspal & Zhi Li & Claire Willis & Tetsuo Hasegawa & Sarah K. Whiteside & David A. Posner & Gianluca Carless, 2024. "Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity," Nature Communications, Nature, vol. 15(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42972-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.